Literature DB >> 7923172

Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA.

J Laliberté1, R L Momparler.   

Abstract

Cytidine (CR) deaminase was purified 47,000-fold to homogeneity from human placenta. The molecular mass of CR deaminase was estimated to be 48.7 kDa by gel filtration and 16.1 kDa by sodium dodecyl sulfate polyacrylamide gel electrophoresis, suggesting that it contains three or four identical subunits. We determined the amino acid sequence of several peptide fragments and designed 5'-primers to amplify, by the polymerase chain reaction, a specific 364-base pair DNA fragment using human liver complementary DNA (cDNA) as the template. This DNA fragment, which contains the codons of one peptide, was used as a probe to screen a cDNA library from human liver. We isolated and sequenced a cDNA clone of 910 base pairs that contained a 5' nontranslated region, a 438-base pair coding region, and a 3' nontranslated region with a polyadenylated tail. The translated region of the clone contained a deduced sequence of 146 amino acids, with a predicted molecular mass of 16.2 kDa and the sequences of our peptides. The cDNA was ligated in pGEX vector and expressed in Escherichia coli. The expressed protein had a high CR deaminase activity and molecular mass of 16.3 kDa. These data demonstrate clearly that the open reading frame of our cDNA clone codes for a functional human CR deaminase. Polymerase chain reaction amplifications of gene-specific DNA fragments from human/rodent hybrid cells indicate the localization of CR deaminase gene to human chromosome 1. The cDNA for CR deaminase will be a useful molecular probe to investigate the importance of this enzyme in chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923172

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?

Authors:  Audrey Frances; Pierre Cordelier
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

2.  Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.

Authors:  Hongmei Ruan; Songbo Qiu; Brian C Beard; Margaret E Black
Journal:  Protein Eng Des Sel       Date:  2016-05-08       Impact factor: 1.650

3.  A rearrangement of the CDD gene at the 5' UTR produces two types of transcripts that contain a natural antisense region.

Authors:  H Jung-Ha; Y Lee; D Kim; B H Song
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

4.  Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles.

Authors:  Dharmika S P Lansakara-P; B Leticia Rodriguez; Zhengrong Cui
Journal:  Int J Pharm       Date:  2012-03-16       Impact factor: 5.875

5.  Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.

Authors:  Sara M Fitzgerald; Rakesh K Goyal; William R A Osborne; Jennifer D Roy; John W Wilson; R E Ferrell
Journal:  Hum Genet       Date:  2006-01-31       Impact factor: 4.132

Review 6.  Clinical potential of elacytarabine in patients with acute myeloid leukemia.

Authors:  Lindsay A M Rein; David A Rizzieri
Journal:  Ther Adv Hematol       Date:  2014-12

7.  Genetic polymorphisms of XPD and CDA and lung cancer risk.

Authors:  Min Zhou; Huan-Ying Wan; Bei-Li Gao; Yong-Jie Ding; Rong-Xia Jun
Journal:  Oncol Lett       Date:  2012-05-15       Impact factor: 2.967

8.  PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.

Authors:  Francesco M Carpi; Silvia Vincenzetti; Daniela Micozzi; Alberto Vita; Valerio Napolioni
Journal:  Mol Biol Rep       Date:  2009-11-26       Impact factor: 2.316

9.  Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2.

Authors:  Misaki Kawasoe; Yasuko Yamamoto; Katsuya Okawa; Tadao Funato; Mayu Takeda; Takeshi Hara; Hisashi Tsurumi; Hisataka Moriwaki; Yuko Arioka; Masao Takemura; Hidetoshi Matsunami; Sanford P Markey; Kuniaki Saito
Journal:  Exp Hematol       Date:  2013-03-15       Impact factor: 3.084

10.  Human cytidine deaminase: a biochemical characterization of its naturally occurring variants.

Authors:  Daniela Micozzi; Francesco Martino Carpi; Stefania Pucciarelli; Valeria Polzonetti; Paolo Polidori; Santiago Vilar; Brian Williams; Stefano Costanzi; Silvia Vincenzetti
Journal:  Int J Biol Macromol       Date:  2013-10-29       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.